Clinical and Experimental Pharmacology and Physiology Issues Research Articles in May 2024 Edition
May 18, 2024
May 18, 2024
TUGGERAH, Australia, May 18 -- Clinical and Experimental Pharmacology and Physiology, a peer-reviewed journal from the High Blood Pressure Research Council of Australia, Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists and Australian Physiological Society, published research articles on the following topics in its May 2024 edition (Vol. 51, Issue 5):
ORIGINAL ARTICLES:
* Exploring the modulatory effects of sotagliflozin on dyslipidemi . . .
ORIGINAL ARTICLES:
* Exploring the modulatory effects of sotagliflozin on dyslipidemi . . .